1-215879002-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS1
This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the p.Ala2774Thr variant in the USH2A gene is 0.13% for European Finnish chromosome by gnomAD (35/25118), and one homozygous European (Finnish) individual and one homozygous European (non-Finnish) individual (BS1_Supporting). The REVEL computational prediction analysis tool predicted a score of 0.052, which meets the threshold to apply BP4. In summary, the HL EP classified this variant as likely benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1_Supporting, BP4. LINK:https://erepo.genome.network/evrepo/ui/classification/CA143621/MONDO:0019501/005
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.8320G>A | p.Ala2774Thr | missense_variant | 42/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.8320G>A | p.Ala2774Thr | missense_variant | 42/72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000674083.1 | c.8320G>A | p.Ala2774Thr | missense_variant | 42/73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.000565 AC: 86AN: 152082Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000544 AC: 136AN: 250090Hom.: 1 AF XY: 0.000577 AC XY: 78AN XY: 135254
GnomAD4 exome AF: 0.000718 AC: 1050AN: 1461772Hom.: 1 Cov.: 32 AF XY: 0.000683 AC XY: 497AN XY: 727196
GnomAD4 genome AF: 0.000565 AC: 86AN: 152200Hom.: 1 Cov.: 32 AF XY: 0.000578 AC XY: 43AN XY: 74406
ClinVar
Submissions by phenotype
Usher syndrome type 2A Uncertain:1Benign:2
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | May 03, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Myriad Genetics, Inc. | Nov 19, 2021 | NM_206933.2(USH2A):c.8320G>A(A2774T) is a missense variant classified as a variant of uncertain significance. A2774T has been observed in cases of USH2A-related disorders (PMID: 25133751, 28041643). Functional studies on this variant are not available. A2774T has been observed in population frequency databases (gnomAD: EUR 0.14%). In summary, there is insufficient evidence to classify NM_206933.2(USH2A):c.8320G>A(A2774T) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. - |
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | May 18, 2021 | - - |
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | USH2A: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | This variant is associated with the following publications: (PMID: 32707200, 28041643) - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 17, 2010 | - - |
Usher syndrome Benign:1
Likely benign, reviewed by expert panel | curation | ClinGen Hearing Loss Variant Curation Expert Panel | Apr 08, 2021 | The filtering allele frequency of the p.Ala2774Thr variant in the USH2A gene is 0.13% for European Finnish chromosome by gnomAD (35/25118), and one homozygous European (Finnish) individual and one homozygous European (non-Finnish) individual (BS1_Supporting). The REVEL computational prediction analysis tool predicted a score of 0.052, which meets the threshold to apply BP4. In summary, the HL EP classified this variant as likely benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BS1_Supporting, BP4. - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 11, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at